» Articles » PMID: 37707834

Regulation of Axon Guidance by Slit2 and Netrin-1 Signaling in the Lacrimal Gland of Aqp5 Knockout Mice

Overview
Specialty Ophthalmology
Date 2023 Sep 14
PMID 37707834
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Dry eye disease (DED) is multifactorial and associated with nerve abnormalities. We explored an Aquaporin 5 (AQP5)-deficiency-induced JunB activation mechanism, which causes abnormal lacrimal gland (LG) nerve distribution through Slit2 upregulation and Netrin-1 repression.

Methods: Aqp5 knockout (Aqp5-/-) and wild-type (Aqp5+/+) mice were studied. LGs were permeabilized and stained with neuronal class III β-tubulin, tyrosine hydroxylase (TH), vasoactive intestinal peptide (VIP), and calcitonin gene-related peptide (CGRP). Whole-mount images were acquired through tissue clearing and 3D fluorescence imaging. Mouse primary trigeminal ganglion (TG) neurons were treated with LG extracts and Netrin-1/Slit2 neutralizing antibody. Transcription factor (TF) prediction and chromatin immunoprecipitation-polymerase chain reaction (ChIP-PCR) experiments verified the JunB binding and regulatory effect on Netrin-1 and Slit2.

Results: Three-dimensional tissue and section immunofluorescence showed reduced LG nerves in Aqp5-/- mice, with sympathetic and sensory nerves significantly decreased. Netrin-1 was reduced and Slit2 increased in Aqp5-/- mice LGs. Aqp5+/+ mice LG tissue extracts (TEs) promoted Aqp5-/- TG neurons axon growth, but Netrin-1 neutralizing antibody (NAb) could inhibit that promotion. Aqp5-/- mice LG TEs inhibited Aqp5+/+ TG axon growth, but Slit2 NAb alleviated that inhibition. Furthermore, JunB, a Netrin-1 and Slit2 TF, could bind them and regulate their expression. SR11302, meanwhile, reversed the Netrin-1 and Slit2 shifts caused by AQP5 deficiency.

Conclusions: AQP5 deficiency causes LG nerve abnormalities. Persistent JunB activation, the common denominator for Netrin-1 suppression and Slit2 induction, was found in Aqp5-/- mice LG epithelial cells. This affected sensory and sympathetic nerve fibers' distribution in LGs. Our findings provide insights into preventing, reversing, and treating DED.

Citing Articles

Screening of pathologically significant diagnostic biomarkers in tears of thyroid eye disease based on bioinformatic analysis and machine learning.

Shu X, Zeng C, Zhu Y, Chen Y, Huang X, Wei R Front Cell Dev Biol. 2024; 12:1486170.

PMID: 39544368 PMC: 11561714. DOI: 10.3389/fcell.2024.1486170.


Nissl Granules, Axonal Regeneration, and Regenerative Therapeutics: A Comprehensive Review.

Bhati M, Thakre S, Anjankar A Cureus. 2023; 15(10):e47872.

PMID: 38022048 PMC: 10681117. DOI: 10.7759/cureus.47872.

References
1.
Karnati R, Laurie D, Laurie G . Lacritin and the tear proteome as natural replacement therapy for dry eye. Exp Eye Res. 2013; 117:39-52. PMC: 3844047. DOI: 10.1016/j.exer.2013.05.020. View

2.
Messmer E . The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015; 112(5):71-81. PMC: 4335585. DOI: 10.3238/arztebl.2015.0071. View

3.
Accogli A, Addour-Boudrahem N, Srour M . Neurogenesis, neuronal migration, and axon guidance. Handb Clin Neurol. 2020; 173:25-42. DOI: 10.1016/B978-0-444-64150-2.00004-6. View

4.
Kossler A, Wang J, Feuer W, Tse D . Neurostimulation of the lacrimal nerve for enhanced tear production. Ophthalmic Plast Reconstr Surg. 2014; 31(2):145-51. PMC: 4329098. DOI: 10.1097/IOP.0000000000000234. View

5.
Dartt D . Neural regulation of lacrimal gland secretory processes: relevance in dry eye diseases. Prog Retin Eye Res. 2009; 28(3):155-77. PMC: 3652637. DOI: 10.1016/j.preteyeres.2009.04.003. View